Completed PHASE2 INTERVENTIONAL 2-arm NCT00261378

Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation (PRECISIONV)

Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation (PRECISION V)

Sponsor: Biocompatibles UK Ltd

Conditions Primary Liver Cancer

Interventions DC Bead with Doxorubicin Transarterialchemoembolisation (TACE)

Updated 8 times since 2017 Last updated: Jul 15, 2021 Started: Nov 30, 2005 Primary completion: Jan 31, 2008 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Primary Liver Cancer and is currently completed. Biocompatibles UK Ltd leads this study, which shows 8 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Sep 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Sep 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Aug 2019 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Aug 2019 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biocompatibles UK Ltd
Boston Scientific Corporation

Data source: Boston Scientific Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bern, Switzerland , Clichy, France , Frankfurt am Main, Germany , Geneva, Switzerland , Hanover, Germany , Innsbruck, Austria , Lausanne, Switzerland , Lille, France , Lyon, France , Mainz, Germany and 7 more locations